Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report

Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report

Abstract Background Satisfactory treatment for patients with unresectable advanced lung cancer has not yet been established. We report a case of unresectable advanced lung cancer (stage IIIb: T2aN3M0) treated with a total of 15 doses of dendritic cells pulsed with a Wilms’ tumor 1 and mucin 1 vaccin...

Full description

Bibliographic Details
Main Authors: Takuya Kosumi, Masanori Kobayashi, Shigetaka Shimodaira, Haruo Sugiyama, Shigeo Koido
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Medical Case Reports
Subjects:
Cancer vaccines
Dendritic cells
WT1
MUC1
Lung cancer
Online Access:https://doi.org/10.1186/s13256-024-04363-z

Internet

https://doi.org/10.1186/s13256-024-04363-z

Similar Items